SIG
58
-2
CCI
36
-5
INTC
37
-4
MSI
69
-3
AEP
59
-3
PM
52
-4
AMAT
49
-3
CME
56
-3
SE
65
4
MRK
53
3
BAC
39
-2
LYB
44
-2
KMI
59
2
MNST
52
2
SPG
53
-2
DLTR
31
3
CHD
53
-3
CTAS
56
-5
QRVO
33
-3
ETR
68
-3
SIG
58
-2
CCI
36
-5
INTC
37
-4
MSI
69
-3
AEP
59
-3
PM
52
-4
AMAT
49
-3
CME
56
-3
SE
65
4
MRK
53
3
BAC
39
-2
LYB
44
-2
KMI
59
2
MNST
52
2
SPG
53
-2
DLTR
31
3
CHD
53
-3
CTAS
56
-5
QRVO
33
-3
ETR
68
-3
Financhill
Back

Gilead Sciences 10K Form

Buy
56

GILD
Gilead Sciences

Last Price:
83.92
Seasonality Move:
1.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q GILD/Gilead Sciences Quarterly
2024-02-23 10K GILD/Gilead Sciences Annual
2023-11-07 10Q GILD/Gilead Sciences Quarterly
2023-08-04 10Q GILD/Gilead Sciences Quarterly
2023-05-03 10Q GILD/Gilead Sciences Quarterly
2023-02-22 10K GILD/Gilead Sciences Annual

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.12B
Cash Flow: $1.2B
Price / Cash Flow: 15.24
Annual Sales: $14.67
Price / Book: 5.71

Profitability

EPS (TTM): 0.82000
Net Income (TTM): $1.05B
Gross Margin: $20.62B
Return on Equity: 5.18%
Return on Assets: 1.78%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 33 years for GILD is 76.04%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 22.46% of Gross Profit Margin.
  • The Research & Development expenses have been 21.09% of Revenue.
  • The Interest Expense is 16.66% of Operating Income.
  • The Net Earning history of GILD is 20.89% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 19 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 1.28
Current Ratio: 1.14
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 18.64
Forward P/E Ratio: 11.76

GILD Technical Analysis vs Fundamental Analysis

Buy
56
Gilead Sciences (GILD) is a Buy

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Buy
    The current Gilead Sciences [GILD] share price is $83.90. The Score for GILD is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.